OBJECTIVE: To evaluate the feasibility and safety of robotic nerve-sparing radical hysterectomy for locally advanced @entity5 (LACC). METHODS: In a retrospective study, data were analyzed for @entity1 treated for @entity5 at a center in Beijing, China, between December 2011 and September 2013. @entity1 were subdivided into those with early-stage disease (FIGO stage IA2-IB1) who were treated by robotic surgery (group 1), and those with LACC (stage IB2-IIB) who were treated by robotic surgery after neoadjuvant chemotherapy (NACT; group 2). Therapeutic outcomes and complications were compared. RESULTS: Group 1 included 32 @entity1 and group 2 included 22 @entity1 . Two @entity1 in group 2 did not respond to NACT and did not undergo surgery. The operative outcomes and incidences of complications did not differ significantly between the two groups (P>0.05 for all). There were no differences in nodal yield, lengths of parametrium removed, or vaginal cuff length (P>0.05 for all). During a mean follow-up of 26months, no @entity1 experienced recurrence. CONCLUSION: Robotic nerve-sparing radical hysterectomy was found to be feasible and safe for LACC after NACT. A larger case series with longer follow-up data is needed to justify its widespread application.

Robotic nerve-sparing radical hysterectomy for locally advanced XXXX after neoadjuvant chemotherapy.

@entity5 :: ('MESH:D009369', 'Disease') :: ['cervical cancer'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'Patients']
@entity5 :: (MESH:D009369,Disease) :: ['cervical cancer']
